Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions
- 1 June 2016
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 28 (3) , 292-308
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council of Australia (APP1082271, 1060538)
- Career Development Fellowship (APP1105420)
This publication has 192 references indexed in Scilit:
- Complement in the brainMolecular Immunology, 2011
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System AtrophyThe American Journal of Pathology, 2011
- CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone modelMolecular Immunology, 2010
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environmentBrain, 2010
- Inflammation in neurodegenerative diseasesImmunology, 2010
- Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic miceProceedings of the National Academy of Sciences, 2009
- Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhageBrain Research, 2009
- Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell deathProceedings of the National Academy of Sciences, 2007
- Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neuronsProceedings of the National Academy of Sciences, 2007